Kamakari Smaragda, Koutsodontis George, Tsilimbaris Miltiadis, Fitsios Athanasios, Chrousos Georgia
Ophthalmic Genetics Unit, OMMA Ophthalmological Institute of Athens, Greece.
Department of Ophthalmology, School of Medicine, University of Crete, Iraklion, Greece.
Mol Vis. 2014 May 27;20:691-703. eCollection 2014.
To describe the genotype-phenotype correlation in four Greek pedigrees with autosomal dominant optic atrophy (ADOA) and OPA1 mutations.
Seven patients from four unrelated families (F1, F2, F3, F4) were clinically assessed for visual acuity, color vision, ptosis, afferent pupillary defects, and visual fields and underwent orthoptic assessment, slit-lamp biomicroscopy, and fundus examination to establish their clinical status. Genomic DNA was extracted from peripheral blood samples from all participants. The coding region (exons 1-28), including the intron-exon boundaries of the OPA1 gene, was screened in the probands of the four families, as well as in seven additional family members (four affected and three unaffected) with PCR and direct DNA sequencing.
All patients presented bilateral decrease in best-corrected visual acuity and temporal pallor of the optic disc. The visual fields of the adult patients showed characteristic scotomata. Other signs were present in some patients such as decreased color discrimination and a gray crescent within the neuroretinal rim. After the OPA1 gene was sequenced, a previously undescribed heterozygous splice-site mutation c.784-1G>T in intron 7 was detected in family F2. In families F1, F3, and F4, a previously reported in-frame deletion c.876_878delTGT/p.(Val294del), the frameshift c.2366delA/p.(Asn789Metfs*11), and splice-site c.1140+5G>C mutations were detected, respectively.
This is the first report of molecular characterization of Greek patients with ADOA. Our findings provide additional information regarding the genotype-phenotype correlation and establish the role of the OPA1 gene in Greek patients with ADOA.
描述四个患有常染色体显性遗传性视神经萎缩(ADOA)和OPA1突变的希腊家系中的基因型-表型相关性。
对来自四个无亲缘关系家庭(F1、F2、F3、F4)的七名患者进行了视力、色觉、上睑下垂、传入性瞳孔缺陷和视野的临床评估,并接受了视光学评估、裂隙灯显微镜检查和眼底检查以确定其临床状况。从所有参与者的外周血样本中提取基因组DNA。使用聚合酶链反应(PCR)和直接DNA测序对四个家庭的先证者以及另外七名家庭成员(四名患者和三名未患病者)的OPA1基因编码区(外显子1-28),包括内含子-外显子边界进行了筛查。
所有患者均表现出最佳矫正视力双侧下降以及视盘颞侧苍白。成年患者的视野显示出特征性暗点。部分患者还存在其他体征,如色觉减退和神经视网膜边缘内的灰色半月形。对OPA1基因进行测序后,在F2家族中检测到一个先前未描述的内含子7杂合剪接位点突变c.784-1G>T。在F1、F3和F4家族中,分别检测到一个先前报道的框内缺失c.876_878delTGT/p.(Val294del)、移码突变c.2366delA/p.(Asn789Metfs*11)和剪接位点突变c.1140+5G>C。
这是关于希腊ADOA患者分子特征的首次报告。我们的研究结果提供了有关基因型-表型相关性的更多信息,并确定了OPA1基因在希腊ADOA患者中的作用。